טוען...
Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List
The availability of oral direct-acting antiviral (DAAs) has altered the hepatitis C virus (HCV) treatment paradigm for both pre- and post-liver transplant (LT) patients. There is a perceived trade-off between pre- versus post-LT treatment of HCV—treatment may improve liver function but potentially d...
שמור ב:
| הוצא לאור ב: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319880/ https://ncbi.nlm.nih.gov/pubmed/27906468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28926 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|